Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Louise Chen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 07/01/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | $160 → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 07/01/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 07/01/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | $215 → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 07/01/2024 | ZLAB | Buy Now | Zai Lab | $16.97 | — | — | Reiterates | → Overweight | Get Alert |
| 06/26/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/26/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/25/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/25/2024 | ZLAB | Buy Now | Zai Lab | $16.97 | — | — | Reiterates | → Overweight | Get Alert |
| 06/25/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | $215 → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 06/24/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | PCVX | Buy Now | Vaxcyte | $79.35 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | MESO | Buy Now | Mesoblast | $7.91 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.27 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | INVA | Buy Now | Innoviva | $16.43 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | IMVT | Buy Now | Immunovant | $27.65 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | EOLS | Buy Now | Evolus | $11.10 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | CDTX | Buy Now | Cidara Therapeutics | $12.16 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | ATOS | Buy Now | Atossa Therapeutics | $1.17 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | ARDX | Buy Now | Ardelyx | $5.46 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | ANL | Buy Now | Adlai Nortye | $3.27 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | AMRN | Buy Now | Amarin Corp | $0.75 | — | — | Reiterates | → Overweight | Get Alert |
| 06/20/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | $160 → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | MRK | Buy Now | Merck & Co | $125.65 | 23.36% | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | $215 → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | ABBV | Buy Now | AbbVie | $167.00 | 19.76% | $200 → $200 | Reiterates | Overweight → Overweight | Get Alert |
| 06/18/2024 | ROIV | Buy Now | Roivant Sciences | $10.87 | — | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | IMVT | Buy Now | Immunovant | $27.65 | — | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | AMRN | Buy Now | Amarin Corp | $0.75 | — | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | INVA | Buy Now | Innoviva | $16.43 | — | — | Initiates | → Overweight | Get Alert |
| 06/18/2024 | MRK | Buy Now | Merck & Co | $125.65 | 23.36% | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | $160 → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/11/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $885 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 06/04/2024 | MRK | Buy Now | Merck & Co | $125.65 | 23.36% | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 06/04/2024 | MESO | Buy Now | Mesoblast | $7.91 | — | — | Reiterates | → Overweight | Get Alert |
| 05/30/2024 | IMVT | Buy Now | Immunovant | $27.65 | — | — | Reiterates | → Overweight | Get Alert |
| 05/17/2024 | ABBV | Buy Now | AbbVie | $167.00 | 19.76% | → $200 | Initiates | → Overweight | Get Alert |
| 05/14/2024 | ATOS | Buy Now | Atossa Therapeutics | $1.17 | — | — | Reiterates | → Overweight | Get Alert |
| 05/09/2024 | PCVX | Buy Now | Vaxcyte | $79.35 | — | — | Reiterates | → Overweight | Get Alert |
| 05/09/2024 | PDSB | Buy Now | PDS Biotechnology | $3.23 | — | — | Reiterates | → Overweight | Get Alert |
| 05/06/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 05/01/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $815 → $885 | Maintains | Overweight | Get Alert |
| 04/30/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -3.59% | $815 → $885 | Reiterates | Overweight → Overweight | Get Alert |
| 04/25/2024 | CDTX | Buy Now | Cidara Therapeutics | $12.16 | — | — | Reiterates | → Overweight | Get Alert |
| 04/23/2024 | CDTX | Buy Now | Cidara Therapeutics | $12.16 | — | — | Reiterates | → Overweight | Get Alert |
| 04/18/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -11.22% | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -11.22% | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/15/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -12.09% | → $925 | Reiterates | Neutral → Neutral | Get Alert |
| 04/05/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/05/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 04/05/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 04/05/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -11.22% | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/04/2024 | SPRO | Buy Now | Spero Therapeutics | $1.32 | — | — | Reiterates | → Overweight | Get Alert |
| 04/01/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | LLY | Buy Now | Eli Lilly and Co | $918.00 | -11.22% | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | SCYX | Buy Now | SCYNEXIS | $1.86 | — | — | Reiterates | → Overweight | Get Alert |
| 04/01/2024 | ZVRA | Buy Now | Zevra Therapeutics | $4.49 | — | — | Reiterates | → Overweight | Get Alert |
| 03/27/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | — | Reiterates | Overweight → Overweight | Get Alert |
| 03/20/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | → $160 | Reiterates | Overweight → Overweight | Get Alert |
| 03/13/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 03/11/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 03/08/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | 11.79% | $140 → $160 | Maintains | Overweight | Get Alert |
| 03/04/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 03/01/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 02/29/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/20/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | -2.19% | → $140 | Reiterates | Overweight → Overweight | Get Alert |
| 02/20/2024 | LLY | Buy Now | Eli Lilly | $918.00 | -11.22% | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 02/20/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/15/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | -2.19% | → $140 | Reiterates | Overweight → Overweight | Get Alert |
| 02/14/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | -2.19% | → $140 | Reiterates | Overweight → Overweight | Get Alert |
| 02/14/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/14/2024 | LLY | Buy Now | Eli Lilly | $918.00 | -11.22% | → $815 | Reiterates | Overweight → Overweight | Get Alert |
| 02/06/2024 | LLY | Buy Now | Eli Lilly | $918.00 | -11.22% | $630 → $815 | Maintains | Overweight | Get Alert |
| 02/06/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/05/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 02/05/2024 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 02/01/2024 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 02/01/2024 | NVO | Buy Now | Novo Nordisk | $143.13 | -2.19% | $120 → $140 | Maintains | Overweight | Get Alert |
| 01/31/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 01/31/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $20.65 | 214.77% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/23/2024 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 01/23/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | PFE | Buy Now | Pfizer | $27.94 | 61.06% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 12/01/2023 | NVO | Buy Now | Novo Nordisk | $143.13 | -16.16% | → $120 | Initiates | → Overweight | Get Alert |
| 11/29/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 11/15/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 11/14/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.29 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/24/2023 | ANL | Buy Now | Adlai Nortye | $3.27 | 817.43% | → $30 | Initiates | → Overweight | Get Alert |
| 10/23/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 10/23/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 10/23/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/23/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 10/18/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/16/2023 | IMVT | Buy Now | Immunovant | $27.65 | 62.75% | $30 → $45 | Maintains | Overweight | Get Alert |
| 10/11/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | ZLAB | Buy Now | Zai Lab | $16.97 | 312.49% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | IMVT | Buy Now | Immunovant | $27.65 | 8.5% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.29 | 2845.74% | → $38 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 10/04/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 10/02/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 10/02/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 10/02/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 10/02/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 09/21/2023 | MESO | Buy Now | Mesoblast | $7.91 | 114.92% | → $68 | Reiterates | Overweight → Overweight | Get Alert |
| 09/19/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.29 | 2845.74% | → $38 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | ZLAB | Buy Now | Zai Lab | $16.97 | 312.49% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | IMVT | Buy Now | Immunovant | $27.65 | 8.5% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | ROIV | Buy Now | Roivant Sciences | $10.87 | 37.99% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/13/2023 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.33 | 275.94% | → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 09/08/2023 | ATOS | Buy Now | Atossa Therapeutics | $1.17 | 327.35% | → $5 | Initiates | → Overweight | Get Alert |
| 09/05/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | IMAB | Buy Now | I-MAB | $1.60 | 1462.5% | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | HCM | Buy Now | HUTCHMED (China) | $16.70 | 199.4% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | ROIV | Buy Now | Roivant Sciences | $10.87 | 37.99% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | ROIV | Buy Now | Roivant Sciences | $10.87 | 37.99% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | MESO | Buy Now | Mesoblast | $7.91 | 114.92% | $92 → $68 | Maintains | Overweight | Get Alert |
| 08/30/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 08/30/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 08/30/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/25/2023 | ARDX | Buy Now | Ardelyx | $5.46 | 83.15% | $5 → $10 | Upgrade | Neutral → Overweight | Get Alert |
| 08/22/2023 | ROIV | Buy Now | Roivant Sciences | $10.87 | 37.99% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | PCVX | Buy Now | Vaxcyte | $79.35 | -11.78% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -31.37% | → $630 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | IMVT | Buy Now | Immunovant | $27.65 | 8.5% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.41 | 380.31% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | ARAV | Buy Now | Aravive | — | — | $18 → $0.25 | Downgrade | Overweight → Neutral | Get Alert |
| 08/22/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/18/2023 | IMAB | Buy Now | I-MAB | $1.60 | 1462.5% | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 08/17/2023 | TXMD | Buy Now | TherapeuticsMD | $1.56 | 220.51% | → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 08/16/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | SCYX | Buy Now | SCYNEXIS | $1.86 | 706.45% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 08/10/2023 | ZLAB | Buy Now | Zai Lab | $16.97 | 312.49% | → $70 | Initiates | → Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -40.09% | → $550 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2023 | CDTX | Buy Now | Cidara Therapeutics | $12.16 | -58.88% | → $100 | Reiterates | Overweight → Overweight | Get Alert |
| 07/31/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2023 | HCM | Buy Now | HUTCHMED (China) | $16.70 | 199.4% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 07/21/2023 | ARAV | Buy Now | Aravive | — | — | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -40.09% | → $550 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | ARAV | Buy Now | Aravive | — | — | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -40.09% | → $550 | Reiterates | Overweight → Overweight | Get Alert |
| 07/10/2023 | ARAV | Buy Now | Aravive | — | — | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 07/03/2023 | ARAV | Buy Now | Aravive | — | — | $18 → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $10.41 | 380.31% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 06/27/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -40.09% | $485 → $550 | Maintains | Overweight | Get Alert |
| 06/23/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 06/22/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -47.17% | → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2023 | ROIV | Buy Now | Roivant Sciences | $10.87 | 37.99% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
| 05/30/2023 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | → $135 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -47.17% | → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 05/22/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -47.17% | $485 → $485 | Reiterates | Overweight → Overweight | Get Alert |
| 05/19/2023 | ONC | Buy Now | Oncolytics Biotech | — | — | $9 → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 05/19/2023 | AMAM | Buy Now | Ambrx Biopharma | — | — | → $25 | Initiates | → Overweight | Get Alert |
| 05/17/2023 | ARAV | Buy Now | Aravive | — | — | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2023 | ONC | Buy Now | Oncolytics Biotech | — | — | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 05/12/2023 | VYNE | Buy Now | VYNE Therapeutics | $1.77 | 408.47% | $5 → $9 | Maintains | Overweight | Get Alert |
| 05/10/2023 | CUTR | Buy Now | Cutera | $1.43 | 1368.53% | $33 → $21 | Maintains | Neutral | Get Alert |
| 04/28/2023 | LLY | Buy Now | Eli Lilly | $918.00 | -47.17% | $432 → $485 | Maintains | Overweight | Get Alert |
| 03/08/2023 | CDTX | Buy Now | Cidara Therapeutics | $12.16 | -58.88% | → $100 | Reiterates | → Overweight | Get Alert |
| 03/06/2023 | ONC | Buy Now | Oncolytics Biotech | — | — | → $9 | Initiates | → Overweight | Get Alert |
| 03/01/2023 | PCVX | Buy Now | Vaxcyte | $79.35 | -11.78% | → $70 | Maintains | Overweight | Get Alert |
| 02/15/2023 | IMVT | Buy Now | Immunovant | $27.65 | 8.5% | → $30 | Initiates | → Overweight | Get Alert |
| 02/07/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.29 | 2845.74% | → $38 | Reiterates | → Overweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $27.94 | 168.43% | → $75 | Reiterates | → Overweight | Get Alert |
| 02/01/2023 | JNJ | Buy Now | Johnson & Johnson | $145.52 | 47.75% | → $215 | Reiterates | → Overweight | Get Alert |
| 02/01/2023 | MESO | Buy Now | Mesoblast | $7.91 | 190.77% | → $92 | Reiterates | → Overweight | Get Alert |
| 01/11/2023 | CUTR | Buy Now | Cutera | $1.43 | 2207.69% | $85 → $33 | Downgrade | Overweight → Neutral | Get Alert |
| 01/11/2023 | TXMD | Buy Now | TherapeuticsMD | $1.56 | 220.51% | → $5 | Reinstates | → Neutral | Get Alert |
| 01/11/2023 | HGEN | Buy Now | Humanigen | $0.00 | 74900% | → $0.15 | Reinstates | → Neutral | Get Alert |
| 12/19/2022 | MRK | Buy Now | Merck & Co | $125.65 | 7.44% | $120 → $135 | Maintains | Overweight | Get Alert |
| 11/08/2022 | PCVX | Buy Now | Vaxcyte | $79.35 | -11.78% | $55 → $70 | Maintains | Overweight | Get Alert |
| 07/14/2022 | CFRX | Buy Now | ContraFect | $0.05 | 1900% | $1200 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 07/13/2022 | TXMD | Buy Now | TherapeuticsMD | $1.56 | -35.9% | → $1 | Reiterates | → Neutral | Get Alert |
| 07/13/2022 | HGEN | Buy Now | Humanigen | $0.00 | 999900% | $30 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 06/02/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $1.33 | 275.94% | → $5 | Initiates | → Overweight | Get Alert |
| 06/01/2022 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $20 | Initiates | → Overweight | Get Alert |
| 05/24/2022 | LYRA | Buy Now | Lyra Therapeutics | $0.27 | 5474.14% | → $15 | Initiates | → Overweight | Get Alert |
| 05/17/2022 | SPRO | Buy Now | Spero Therapeutics | $1.32 | 278.79% | $27 → $5 | Maintains | Overweight | Get Alert |
| 05/06/2022 | ARDX | Buy Now | Ardelyx | $5.46 | — | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2022 | TXMD | Buy Now | TherapeuticsMD | $1.56 | -35.9% | $250 → $50 | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2022 | ETTX | Buy Now | Entasis Therapeutics Hldg | — | — | $5 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 04/29/2022 | ROIV | Buy Now | Roivant Sciences | $10.87 | 37.99% | → $15 | Initiates | → Overweight | Get Alert |
| 09/13/2021 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.08 | 63756.96% | → $1250 | Initiates | → Overweight | Get Alert |
| 07/07/2021 | JAGX | Buy Now | Jaguar Health | $4.00 | 25% | → $67500 | Initiates | → Overweight | Get Alert |
